Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

Scintigraphy for Prediction In Rheumatoid Intentional Therapy Tapering

NCT05983848 ·Status: NOT_YET_RECRUITING

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

NCT00796705 ·Status: TERMINATED ·Phase: PHASE4

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473 ·Status: COMPLETED

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

NCT01357668 ·Status: ACTIVE_NOT_RECRUITING

Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

NCT01691014 ·Status: TERMINATED

Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs

NCT03496831 ·Status: COMPLETED

Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia

NCT02778906 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France

NCT02927535 ·Status: COMPLETED

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

NCT02804204 ·Status: UNKNOWN

Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use

NCT01083160 ·Status: TERMINATED

Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation

NCT04393233 ·Status: COMPLETED

Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice

NCT02202837 ·Status: COMPLETED

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography

NCT00767325 ·Status: COMPLETED ·Phase: PHASE3

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

NCT05421442 ·Status: COMPLETED

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

NCT01783015 ·Status: TERMINATED ·Phase: PHASE4

A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis

NCT04574492 ·Status: COMPLETED

Enbrel Liquid Immunogenicity Protocol

NCT00249041 ·Status: COMPLETED ·Phase: PHASE3

Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis

NCT05119452 ·Status: UNKNOWN ·Phase: NA

An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis

NCT04267536 ·Status: COMPLETED

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

NCT03414502 ·Status: RECRUITING ·Phase: PHASE3

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients

NCT00979771 ·Status: WITHDRAWN ·Phase: PHASE2

Remission Induction in Very Early Rheumatoid Arthritis

NCT00523692 ·Status: UNKNOWN ·Phase: PHASE4

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

NCT00989235 ·Status: COMPLETED ·Phase: PHASE3